\n\n7.2 micrograms \/ 5 micrograms inhalation spray , suspension glycopyrronium \/ formoterol fumarate dihydrate
<\/p>\n\n\n\n
Bevespi Aerosphere contains two active substances called glycopyrronium and formoterol fumarate dihydrate. These belong to a group of drugs called long-acting bronchodilators.<\/p>\n\n\n\n
Bevespi Aerosphere is used to make it easier for adults to have a lung disease called COPD (chronic obstructive pulmonary disease ). COPD is a long-term disease of the lungs’ airways, which is often caused by smoking. If you have COPD, the muscles in the trachea become tense, which makes it difficult to breathe.<\/p>\n\n\n\n
This medicine prevents the muscles in the trachea from becoming tense, making it easier for air to get in and out of the lungs.<\/p>\n\n\n\n
Bevespi Aerosphere delivers the active ingredients directly to the lungs’ airways when you inhale. This will help reduce the effects of COPD in your daily life<\/p>\n\n\n\n
Bevespi Aerosphere is regularly used as a long-term treatment for COPD. Do not use this medicine to treat sudden attacks of shortness of breath or wheezing.
<\/p>\n\n\n\n
Sudden difficulty breathing<\/strong><\/p>\n\n\n\n If you get pressure over your chest, cough, wheeze or shortness of breath immediately after using Bevespi Aerosphere:<\/p>\n\n\n\n Stop using this medicine and seek immediate medical attention<\/strong> as this may be a serious condition called parodoxal bronchospasm. Talk to your doctor or pharmacist before using Bevespi Aerosphere<\/strong><\/p>\n\n\n\n Always tell your doctor about other health problems.<\/p>\n\n\n\n Bevespi Aerosphere should not be used by children and adolescents under 18 years of age.<\/p>\n\n\n\n Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.<\/p>\n\n\n\n Some medicines may affect the way this medicine works or make you more likely to experience side effects. These medicines include:<\/p>\n\n\n\n If any of the above apply to you, or if you are not sure, talk to your doctor or pharmacist before using Bevespi Aerosphere.<\/p>\n\n\n\n If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using Bevespi Aerosphere. Do not use Bevespi Aerosphere if you are pregnant unless your doctor tells you to. Do not use Bevespi Aerosphere if you are breast-feeding unless your doctor tells you to<\/p>\n\n\n\n It is unlikely that this medicine will affect your ability to drive or use machines. However, dizziness and nausea are common side effects that can occur. If this occurs, do not drive or use machines. Always take this medicine exactly as your doctor has told you. Ask your doctor or pharmacist if you are unsure. How much to use<\/strong><\/p>\n\n\n\n The recommended dose is two puffs twice daily.<\/p>\n\n\n\n It is important that you use Bevespi Aerosphere every day, even if you do not have any symptoms of COPD at that time. How to use Bevespi Aerosphere<\/strong><\/p>\n\n\n\n Bevespi Aerosphere is intended for inhalation .<\/p>\n\n\n\n Read the instructions for use at the end of this leaflet. If you are not sure how to use Bevespi Aerosphere, talk to your doctor or pharmacist. Use of Bevespi Aerosphere with a respirator<\/strong><\/p>\n\n\n\n If you have problems breathing in and pressing the inhaler at the same time, talk to your doctor or pharmacist. It is possible that you can use a “breathing container” together with your inhaler.<\/p>\n\n\n\n If you have used more Bevespi Aerosphere than you should contact a doctor or pharmacist immediately. You may need medical attention. You may feel your heartbeat faster than normal, feel shaky, have visual disturbances, have a dry mouth, have a headache, or feel nauseous.<\/p>\n\n\n\n Do not take a double dose to make up for a forgotten dose . Take it as soon as you remember. However, if it is soon time to take the next dose, skip the missed dose. Do not take more than two puffs twice daily.<\/p>\n\n\n\n This medicine is for long-term use. It will only take effect while you use it. Do not stop taking this medicine unless your doctor tells you to, even if you feel better, as your symptoms may get worse. If you want to stop treatment, talk to your doctor first. If you have any further questions on the use of this product, ask your doctor or pharmacist.<\/p>\n\n\n\n Like all medicines, this medicine can cause side effects , although not everybody gets them. Serious side effects are<\/strong><\/p>\n\n\n\n Stop using Bevespi Aerosphere and contact a doctor immediately if you experience any of the following symptoms: Uncommon:<\/strong> may affect up to 1 in 100 people<\/p>\n\n\n\n These symptoms may be a sign of a severe allergic reaction . Other possible side effects are<\/strong> Common<\/strong>: may affect up to 1 in 10 users<\/p>\n\n\n\n Uncommon<\/strong> : may affect up to 1 in 100 people<\/p>\n\n\n\n Reporting of side effects<\/em><\/p>\n\n\n\n If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Medical Products Agency, www.lakemedelsverket.se. By reporting side effects, you can help increase drug safety information. <\/p>\n\n\n\n Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton, bag, or pressure container after \u201cEXP\u201d. The expiration date is the last day of the specified month. Once opened, the inhaler can be used for up to 3 months. Write down the date the bag was opened in the designated place on the inhaler label. Do not store above 30 \u00b0 C. Warning:<\/strong> Do not destroy, puncture, or burn the pressure vessel, even if it appears empty. Do not expose the container to temperatures above 50 \u00b0 C. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.<\/p>\n\n\n\n Each individual puff provides an added dose of 9 micrograms glycopyrronium bromide (equivalent to 7.2 micrograms glycopyrronium) and 5 micrograms formoterol fumarate dihydrate. Other ingredients are norflurane, 1,2-distearoyl-sn-glycero-3-phosphocholine, and calcium chloride.<\/p>\n\n\n\n Bevespi Aerosphere is an inhalation spray , suspension .<\/p>\n\n\n\n Bevespi Aerosphere consists of a pressure container with a dose indicator, equipped with a white plastic adapter and a nozzle (see figure 1 in the operating instructions at the end of this leaflet). The nozzle has an orange protective cover. Bevespi Aerosphere comes in a foil bag that contains a desiccant and is packed in a carton. The active ingredients are contained in a suspension inside the pressure vessel. Bevespi Aerosphere in packs containing an inhaler with 120 puffs and in multipacks containing three inhalers s each with 120 puffs. Not all pack sizes may be marketed.<\/p>\n\n\n\n Marketing Authorisation Holder:<\/strong><\/p>\n\n\n\n Manufacturer:<\/strong><\/p>\n\n\n\n AstraZeneca Dunkirk Production<\/p>\n\n\n\n 224 Avenue de la Dordogne<\/p>\n\n\n\n Dunkirk<\/p>\n\n\n\n 59640<\/p>\n\n\n\n France AstraZeneca GmbH<\/p>\n\n\n\n Tinsdaler Weg 183<\/p>\n\n\n\n 22880 Wedel<\/p>\n\n\n\n Germany Contact the representative of the marketing authorization holder to find out more about this medicine:<\/p>\n\n\n\n Bevespi Aerosphere contains two active substances called glycopyrronium and formoterol fumarate dihydrate. These belong to a group of drugs called long-acting bronchodilators.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"categories":[2202,2200],"tags":[8910,8914,8918,8921,8913,8917,8912,8916,8920,8911,8915,8919],"class_list":["post-6036","post","type-post","status-publish","format-standard","hentry","category-b","category-medicines","tag-bevespi-aerosphere","tag-formoterol","tag-glycopyrronium","tag-glycopyrronium-side-effects","tag-side-effects-of-bevespi-aerosphere","tag-side-effects-of-formoterol","tag-what-bevespi-aerosphere-is-used-for","tag-what-formoterol-is-used-for","tag-what-glycopyrronium-is-used-for","tag-what-is-bevespi-aerosphere","tag-what-is-formoterol","tag-what-is-glycopyrronium"],"_links":{"self":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/6036","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/comments?post=6036"}],"version-history":[{"count":5,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/6036\/revisions"}],"predecessor-version":[{"id":12030,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/6036\/revisions\/12030"}],"wp:attachment":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/media?parent=6036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/categories?post=6036"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/tags?post=6036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
<\/p>\n\n\n\nChildren and young people<\/h2>\n\n\n\n
Other medicines and Bevespi Aerosphere<\/h2>\n\n\n\n
Pregnancy and breastfeeding<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\nDriving and using machines<\/h2>\n\n\n\n
<\/p>\n\n\n\n3. How to use Bevespi Aerosphere<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\nIf you use more Bevespi Aerosphere than you should <\/h2>\n\n\n\n
If you forget to use Bevespi Aerosphere<\/h2>\n\n\n\n
If you stop using Bevespi Aerosphere<\/h2>\n\n\n\n
<\/p>\n\n\n\n4. Possible side effects<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n5. How to store Bevespi Aerosphere<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n6. Contents of the packaging and other information<\/h2>\n\n\n\n
Content declaration<\/h2>\n\n\n\n
<\/p>\n\n\n\nWhat the medicine looks like and contents of the pack<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\nMarketing Authorization Holder and Manufacturer<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\nBelgium \/ Belgique \/ Belgien<\/strong>AstraZeneca SA \/ NVTel: +32 2 370 48 11<\/td> Lithuania<\/strong>UAB AstraZeneca LietuvaTel: +370 5 2660550<\/td><\/tr> Bulgaria<\/strong>Astrology Bulgaria BODYTel: +359 24455000<\/td> Luxembourg \/ Luxemburg<\/strong>AstraZeneca SA \/ NVTel: +32 2 370 48 11<\/td><\/tr> Czech Republic<\/strong>AstraZeneca Czech Republic sroTel: +420 222 807 111<\/td> Hungary<\/strong>AstraZeneca Kft.Tel .: +36 1 883 6500<\/td><\/tr> Denmark<\/strong>AstraZeneca A \/ STel: +45 43 66 64 62<\/td> Malta<\/strong>Associated Drug Co. Ltd.Tel: +356 2277 8000<\/td><\/tr> Germany<\/strong>AstraZeneca GmbHTel: +49 41 03 7080<\/td> The Netherlands<\/strong>AstraZeneca BVTel: +31 79 363 2222<\/td><\/tr> Eesti<\/strong>AstraZenecaTel: +372 6549 600<\/td> Norway<\/strong>AstraZeneca ASTel: +47 21 00 64 00<\/td><\/tr> Greece<\/strong>AstraZeneca AE:\u0397\u03bb: +30 210 6871500<\/td> Austria<\/strong>AstraZeneca \u00d6sterreich GmbHTel: +43 1 711 31 0<\/td><\/tr> Spain<\/strong>AstraZeneca Pharmac\u00e9utica Spain, SATel: +34 91 301 91 00<\/td> Poland<\/strong>AstraZeneca Pharma Poland Sp. z ooTel .: +48 22 245 73 00<\/td><\/tr> France<\/strong>AstraZenecaTel: +33 1 41 29 40 00<\/td> Portugal<\/strong>AstraZeneca Pharmaceutical Products, Lda.Tel: +351 21 434 61 00<\/td><\/tr> Croatia<\/strong>AstraZeneca dooTel: +385 1 4628 000<\/td> Romania<\/strong>AstraZeneca Pharma SRLTel: +40 21 317 60 41<\/td><\/tr> Ireland<\/strong>AstraZeneca Pharmaceuticals (Ireland) LtdTel: +353 1609 7100<\/td> Slovenia<\/strong>AstraZeneca UK LimitedTel: +386 1 51 35 600<\/td><\/tr> Iceland<\/strong>Vistor hf.Phone: +354 535 7000<\/td> Slovak Republic<\/strong>AstraZeneca AB, ozTel: +421 2 5737 7777<\/td><\/tr> Italy<\/strong>AstraZeneca SpATel: +39 02 9801 1<\/td> Finland \/ Finland<\/strong>AstraZeneca OyPuh \/ Tel: +358 10 23 010<\/td><\/tr> \u039a\u03cd\u03c0\u03c1\u03bf\u03c2<\/strong>Alexander the Great:\u0397\u03bb: +357 22490305<\/td> <\/td><\/tr> Latvia<\/strong>SIA AstraZeneca LatvijaTel: +371 67377100<\/td> United Kingdom<\/strong>AstraZeneca UK LtdTel: +44 1582 836 836<\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"